House Ways and Means Comments on Drug Price Controls

House Ways and Means Committee Chairman Jason Smith (MO-08) comments on the Biden-Harris Administration’s recent announcement regarding price controls for ten specific medications. In his 8/15/2024 press release, Smith cites the cost increases and research and development impediments expected to result from the price-setting move. Read the full press release here…

The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or socialsecurityreport.org.

What's Your Opinion?

We welcome your comments. Join the discussion and let your voice be heard. All fields are required

Website by Geiger Computers